-
公开(公告)号:ZA7407042B
公开(公告)日:1975-11-26
申请号:ZA7407042
申请日:1974-11-01
Applicant: HOECHST AG
Inventor: SCHRINNER E , GERHARDS H , HARTUNG H , DUERCKHEIMER W
IPC: C07D295/14 , A61K20060101 , A61K31/65 , C07C20060101 , C07C67/00 , C07C231/00 , C07C231/08 , C07C237/26 , C07D20060101 , C07D207/16 , C07D211/34 , C07D211/62 , C07D227/00 , C07D235/12 , C07D269/00 , C07D295/02 , C07D295/04 , C07C , C07D
CPC classification number: C07D405/04
-
公开(公告)号:DK158175A
公开(公告)日:1975-10-14
申请号:DK158175
申请日:1975-04-11
Applicant: HOECHST AG
Inventor: MARTIN W , DYRCKHEIMER W , SCHRINNER E
IPC: C07D319/06 , C07C67/00 , C07C231/00 , C07C231/08 , C07C231/12 , C07C237/26 , C07D211/34 , C07D211/62 , C07D295/13 , C07C
Abstract: Antibacterially-active tetracyclines, substituted at the amide group, and physiologically-tolerable salts thereof, said tetracyclines having the formula METHODS OF MAKING THE SAME; PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
-
公开(公告)号:IE34536B1
公开(公告)日:1975-06-11
申请号:IE121270
申请日:1970-09-18
Applicant: HOECHST AG
Inventor: SCHORR M , SCHRINNER E , SCHUTZE E
IPC: C07D233/22 , C07D499/00 , C07D499/44 , C07D499/48 , C07D99/14 , C07D99/22 , A61K21/00
Abstract: 1285790 Acylaminopenicillins FARBWERKE HOECHST AG 28 Sept 1970 [27 Sept 1969 (2)] 46107/70 Headings C2A andC2C Novel acylaminopenicillanic acids of Formula I wherein R 1 and R 2 are the same or different and are hydrogen or C 1 to C 5 alkyl or together form an optionally substituted alkylene group linking the nitrogen atoms, R 3 is hydrogen or C 1 to C 5 alkyl, A is an optionally substituted phenylene or thienylene group and B is oxygen or a chemical bond, and salts thereof, are prepared by reacting 6-aminopenicillanic acid or a salt thereof with a carboxylic acid of Formula II wherein R 1 , R 2 , R 3 , A and B are as defined above or an N-acylating derivative or salt thereof. The groups R1, R 2 and R 3 preferably contain a total of not more than 6 carbon atoms. When R 1 and R 2 form an alkylene group, this may be substituted, e.g. by C 1 to C 5 alkyl groups which may be closed into a ring and this ring may include a hetero atom. A is preferably 1,4-phenylene or 2,5-thienylene and may be substituted, e.g. by alkyl, alkoxy and/or halogen. The reaction may be carried out in water, preferably together with a water-miscible solvent, at pH 6-9 and at ambient temperature or below; an acid-acceptor, e.g. NaHC0 3 or triethylamine, is preferably present in the medium. The product may be isolated by simply lyophilizing the reaction mixture to give the penicillin in the form of a crude mixture with salts (e.g. NaCl) formed as by-products, which may be used therapeutically without purification providing the salts are non-toxic. It is purified by re-crystallization from concentrated aqueous solution. The acid chlorides of 4-amidinophenylacetic acid, 4-amidmophenoxyacetic acid and 4-(2- imidazolinyl)-phenoxyacetic acid as their hydrochloride salts are prepared by reacting the acid with thionyl chloride. Pharmaceutical compositions having antibacterial activity against gram-positive and gramnegative bacteria comprise an acylaminopenicillanic acid of Formula I as defined above or a physiologically tolerable salt thereof together with a pharmaceutical carrier.
-
公开(公告)号:NL7013978A
公开(公告)日:1971-03-30
申请号:NL7013978
申请日:1970-09-22
Applicant: HOECHST AG
Inventor: SCHORR M , SCHRINNER E , SCHUTZE E
IPC: C07D233/22 , C07D499/00 , C07D499/44 , C07D499/48 , C07D99/16 , A61K27/00
Abstract: 1285790 Acylaminopenicillins FARBWERKE HOECHST AG 28 Sept 1970 [27 Sept 1969 (2)] 46107/70 Headings C2A andC2C Novel acylaminopenicillanic acids of Formula I wherein R 1 and R 2 are the same or different and are hydrogen or C 1 to C 5 alkyl or together form an optionally substituted alkylene group linking the nitrogen atoms, R 3 is hydrogen or C 1 to C 5 alkyl, A is an optionally substituted phenylene or thienylene group and B is oxygen or a chemical bond, and salts thereof, are prepared by reacting 6-aminopenicillanic acid or a salt thereof with a carboxylic acid of Formula II wherein R 1 , R 2 , R 3 , A and B are as defined above or an N-acylating derivative or salt thereof. The groups R1, R 2 and R 3 preferably contain a total of not more than 6 carbon atoms. When R 1 and R 2 form an alkylene group, this may be substituted, e.g. by C 1 to C 5 alkyl groups which may be closed into a ring and this ring may include a hetero atom. A is preferably 1,4-phenylene or 2,5-thienylene and may be substituted, e.g. by alkyl, alkoxy and/or halogen. The reaction may be carried out in water, preferably together with a water-miscible solvent, at pH 6-9 and at ambient temperature or below; an acid-acceptor, e.g. NaHC0 3 or triethylamine, is preferably present in the medium. The product may be isolated by simply lyophilizing the reaction mixture to give the penicillin in the form of a crude mixture with salts (e.g. NaCl) formed as by-products, which may be used therapeutically without purification providing the salts are non-toxic. It is purified by re-crystallization from concentrated aqueous solution. The acid chlorides of 4-amidinophenylacetic acid, 4-amidmophenoxyacetic acid and 4-(2- imidazolinyl)-phenoxyacetic acid as their hydrochloride salts are prepared by reacting the acid with thionyl chloride. Pharmaceutical compositions having antibacterial activity against gram-positive and gramnegative bacteria comprise an acylaminopenicillanic acid of Formula I as defined above or a physiologically tolerable salt thereof together with a pharmaceutical carrier.
-
公开(公告)号:BE756747A
公开(公告)日:1971-03-29
申请号:BE756747D
Applicant: HOECHST AG
Inventor: SCHORR M , SCHRINNER E , SCHUTZE E
IPC: C07D233/22 , C07D499/00 , C07D499/44 , C07D499/48 , C07D
Abstract: 1285790 Acylaminopenicillins FARBWERKE HOECHST AG 28 Sept 1970 [27 Sept 1969 (2)] 46107/70 Headings C2A andC2C Novel acylaminopenicillanic acids of Formula I wherein R 1 and R 2 are the same or different and are hydrogen or C 1 to C 5 alkyl or together form an optionally substituted alkylene group linking the nitrogen atoms, R 3 is hydrogen or C 1 to C 5 alkyl, A is an optionally substituted phenylene or thienylene group and B is oxygen or a chemical bond, and salts thereof, are prepared by reacting 6-aminopenicillanic acid or a salt thereof with a carboxylic acid of Formula II wherein R 1 , R 2 , R 3 , A and B are as defined above or an N-acylating derivative or salt thereof. The groups R1, R 2 and R 3 preferably contain a total of not more than 6 carbon atoms. When R 1 and R 2 form an alkylene group, this may be substituted, e.g. by C 1 to C 5 alkyl groups which may be closed into a ring and this ring may include a hetero atom. A is preferably 1,4-phenylene or 2,5-thienylene and may be substituted, e.g. by alkyl, alkoxy and/or halogen. The reaction may be carried out in water, preferably together with a water-miscible solvent, at pH 6-9 and at ambient temperature or below; an acid-acceptor, e.g. NaHC0 3 or triethylamine, is preferably present in the medium. The product may be isolated by simply lyophilizing the reaction mixture to give the penicillin in the form of a crude mixture with salts (e.g. NaCl) formed as by-products, which may be used therapeutically without purification providing the salts are non-toxic. It is purified by re-crystallization from concentrated aqueous solution. The acid chlorides of 4-amidinophenylacetic acid, 4-amidmophenoxyacetic acid and 4-(2- imidazolinyl)-phenoxyacetic acid as their hydrochloride salts are prepared by reacting the acid with thionyl chloride. Pharmaceutical compositions having antibacterial activity against gram-positive and gramnegative bacteria comprise an acylaminopenicillanic acid of Formula I as defined above or a physiologically tolerable salt thereof together with a pharmaceutical carrier.
-
公开(公告)号:SE325889B
公开(公告)日:1970-07-13
申请号:SE966566
申请日:1966-07-14
Applicant: HOECHST AG
Inventor: WOLF E , SCHRINNER E
IPC: A61K31/505 , C07D239/92 , C07D51/48
-
公开(公告)号:NZ220509A
公开(公告)日:1989-11-28
申请号:NZ22050987
申请日:1987-06-02
Applicant: HOECHST AG
Inventor: LIMBERT M , SCHRINNER E , SEIBERT G
IPC: A61K31/545 , A61P31/04 , A61K31/43
Abstract: Pharmaceutical preparation having a synergistic, antibacterial activity and containing a) a cephalosporin derivative or physiologically acceptable salts or esters thereof, and b) a penem antibiotic of the basic structure (B) or physiologically acceptable salts or esters thereof, process for manufacturing such a preparation, and its use in the treatment of bacterial infections.
-
公开(公告)号:YU76578A
公开(公告)日:1983-04-30
申请号:YU76578
申请日:1978-03-31
Applicant: HOECHST AG
Inventor: EHLERS E , BORMANN D , DUERCKHEIMER W , SCHRINNER E , HEYMES R
IPC: A61K31/397 , A61K31/435 , A61K31/505 , A61K31/535 , A61K31/545 , A61K31/546 , A61P31/04 , B25J15/08 , C07D205/08 , C07D277/20 , C07D277/40 , C07D277/42 , C07D277/50 , C07D463/00 , C07D471/04 , C07D487/04 , C07D498/04 , C07D501/20 , C07D501/24 , C07D501/36 , C07D505/00 , C07D519/06 , C07F9/6561 , C07D501/00 , A61K31/345
Abstract: Cephem derivatives of the general formula in which the R2O group is in the syn-position, a process for their manufacture and pharmaceutical formulations which are active against bacterial infections and contain these compounds.
-
公开(公告)号:ZA781870B
公开(公告)日:1979-03-28
申请号:ZA781870
申请日:1978-03-31
Applicant: HOECHST AG
Inventor: BORMANN D , DUERCKHEIMER W , EHLERS E , SCHRINNER E , HEYMES R
IPC: C07D501/36 , A61K31/545 , A61K31/546 , A61P31/04 , C07D501/20 , C07D501/46
-
公开(公告)号:DK143378A
公开(公告)日:1978-10-03
申请号:DK143378
申请日:1978-03-31
Applicant: HOECHST AG
Inventor: DUERCKHEIMER W , BORMANN D , EHLERS E , SCHRINNER E , HEYMES R
IPC: A61K31/397 , A61K31/435 , A61K31/505 , A61K31/535 , A61K31/545 , A61K31/546 , A61P31/04 , B25J15/08 , C07D205/08 , C07D277/20 , C07D277/40 , C07D277/42 , C07D277/50 , C07D463/00 , C07D471/04 , C07D487/04 , C07D498/04 , C07D501/20 , C07D501/24 , C07D501/36 , C07D505/00 , C07D519/06 , C07F9/6561 , C07D
Abstract: Cephem derivatives of the general formula in which the R2O group is in the syn-position, a process for their manufacture and pharmaceutical formulations which are active against bacterial infections and contain these compounds.
-
-
-
-
-
-
-
-
-